G Protein News and Research

RSS

New maintenance medium for human embryonic and pluripotent stem cells

STEMCELL Technologies Inc. (STEMCELL) is pleased to announce the release of TeSR™2, a defined, animal-protein free maintenance medium for human embryonic and induced pluripotent stem cells. This medium takes a step towards addressing the needs of researchers working towards the culture of their cells in a medium free of animal-derived proteins.

15 Oct 2009

MSU receives $6.2 million Morris K. Udall Center of Excellence for Parkinson's disease grant

A team of researchers from Michigan State University and the University of Cincinnati have been awarded a $6.2 million Morris K. Udall Center of Excellence for Parkinson's disease grant.

15 Oct 2009

UT Southwestern Medical Center awarded $15.7M NIH contract to develop a new virus database

The National Institutes of Health has awarded a $15.7 million contract to UT Southwestern Medical Center and Northrop Grumman Corp. to develop an open-access national online database and analysis resource center that will help scientists study and combat viruses such as those that cause hepatitis, encephalitis, smallpox, acute respiratory distress and dengue fever, as well as newly emerging pathogenic viruses.

15 Oct 2009

Curemark commences enrollment in Phase III CM-AT clinical trials for autism treatment

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its autism treatment, CM-AT. The first clinical trial patients have been enrolled at Lake Mary Pediatrics in Orange City, Florida, one of 12 clinical trial sites with a total 170 children across the country.

15 Oct 2009

Genetic diversity thwarts the usefulness of malaria vaccine

Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. While there is no approved vaccine for malaria, various experimental vaccines are in development.

15 Oct 2009

FDA approves ZyStor Therapeutics' ZC-701 for Phase I human safety trial

ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.

14 Oct 2009

Medtronic announces results of study comparing INFUSE Bone Graft to autogenous bone graft

Medtronic, Inc. today announced results of a study comparing the safety and effectiveness of INFUSE® Bone Graft to autogenous bone graft (bone harvested from the patient) when used in maxillary sinus floor augmentation.

14 Oct 2009

Global Bioenergies discovers synthetic metabolic pathway for producing isobutene

Global Bioenergies, located on the Genopole campus close to Paris, has today announced the proof-of-concept of a synthetic metabolic pathway for producing isobutene, a key building block that can be converted into transportation fuels, polymers and various commodity chemicals.

14 Oct 2009

European Patent Office to grant two intellectual property patents to Athera Biotechnologies

Athera Biotechnologies AB, an atherosclerosis R&D company developing novel products for treatment and prevention of cardiovascular disease (CVD), announced today that the European Patent Office intends to grant two key patents related to the Company's intellectual property on its two pharmaceutical candidates Annexin A5 and PC-mAb.

14 Oct 2009

Presentation on L-DOS47 drug formulation and development at Pharmaceutical Industry Conference

Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) today announced that a presentation on L-DOS47 formulation and analytical method development will be made at the "Formulation Strategies for Protein Therapeutics" conference to be held on October 13 to 15, 2009, in Raleigh, North Carolina. The conference is sponsored by IBC Life Sciences.

14 Oct 2009

MUC1 protein defends against the stomach ulcer bacterium, according to study

A special protein in the lining of the stomach has been shown to be an important part of the body's defense against the stomach ulcer bacterium Helicobacter pylori in a new study from the Sahlgrenska Academy at the University of Gothenburg. The discovery may explain why the bacterium makes some people more ill than others.

14 Oct 2009

Integrated Diagnostics launched to develop diagnostic tools and innovative biomarkers

Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins.

14 Oct 2009

Researchers develop magneto-nano sensor chip to detect cancer

Searching for biomarkers that can warn of diseases such as cancer while they are still in their earliest stage is likely to become far easier thanks to an innovative biosensor chip developed by Stanford University researchers.

14 Oct 2009

Brain researcher finds how the epilepsy and pain drug works

A Duke University Medical Center researcher who spent years looking for the signals that prompt the brain to form new connections between neurons has found one that may explain precisely how a well-known drug for epilepsy and pain actually works.

14 Oct 2009

NYU-Poly scientists develop a new method of protein stabilization

Scientists at the Polytechnic Institute of New York University report they have developed a novel method of stabilizing proteins, including important enzymes used to produce certain artificial sweeteners and bio-ethanol.

14 Oct 2009

Researchers discover compounds that show promise as novel treatments for AIDS

While studying an HIV protein that plays an essential role in AIDS progression, researchers at the University of Pittsburgh School of Medicine have discovered compounds that show promise as novel treatments for the disease.

14 Oct 2009

Researchers discover new cancer gene that causes adenoid cystic carcinoma

The cancer caused by this new cancer gene is called adenoid cystic carcinoma and is a slow-growing but deadly form of cancer. The research group can now show that the gene is found in 100% of these tumours, which means that a genetic test can easily be used to make a correct diagnosis.

14 Oct 2009

NIH awards Novavax a SBIR grant for respiratory syncytial virus vaccine research

Novavax, Inc. announced today that it has received a Small Business and Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The grant from the NIAID is to support a segment of the Company's preclinical research program for the respiratory syncytial virus (RSV) particle-based vaccine.

14 Oct 2009

Good nutrition and exercise vital to stay young and healthy

Keeping fit at a young age may be one of the secrets to living a long and healthy life, according to new research co-authored by researcher Oscar Franco, MD, PhD, Assistant Clinical Professor in Public Health at the University of Warwick in the United Kingdom.

14 Oct 2009

Gene variations increase the risk of sudden cardiac death

A multi-national research team has discovered that two genetic factors converge to increase the risk of sudden cardiac death.

14 Oct 2009

G Protein News and Research

New maintenance medium for human embryonic and pluripotent stem cells

MSU receives $6.2 million Morris K. Udall Center of Excellence for Parkinson's disease grant

UT Southwestern Medical Center awarded $15.7M NIH contract to develop a new virus database

Curemark commences enrollment in Phase III CM-AT clinical trials for autism treatment

Genetic diversity thwarts the usefulness of malaria vaccine

FDA approves ZyStor Therapeutics' ZC-701 for Phase I human safety trial

Medtronic announces results of study comparing INFUSE Bone Graft to autogenous bone graft

Global Bioenergies discovers synthetic metabolic pathway for producing isobutene

European Patent Office to grant two intellectual property patents to Athera Biotechnologies

Presentation on L-DOS47 drug formulation and development at Pharmaceutical Industry Conference

MUC1 protein defends against the stomach ulcer bacterium, according to study

Integrated Diagnostics launched to develop diagnostic tools and innovative biomarkers

Researchers develop magneto-nano sensor chip to detect cancer

Brain researcher finds how the epilepsy and pain drug works

NYU-Poly scientists develop a new method of protein stabilization

Researchers discover compounds that show promise as novel treatments for AIDS

Researchers discover new cancer gene that causes adenoid cystic carcinoma

NIH awards Novavax a SBIR grant for respiratory syncytial virus vaccine research

Good nutrition and exercise vital to stay young and healthy

Gene variations increase the risk of sudden cardiac death

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News